Latest

psilocybin

·November 19, 2021·5 min read

Psychedelics Show Promise in Treating Mental Illness

A growing body of evidence suggests psychedelics including psilocybin and LSD show promise in providing lasting relief from symptoms for those suffering some mental health disorders. Researchers found DOI, a similar drug to LSD, reduced negative behavioral responses following fear triggers in mouse models of anxiety.

Auditory Neuroscience Featured Neuroscience Psychology

·October 5, 2021·4 min read

Psilocybin Affects Perception of Music

Psilocybin, a natural psychoactive compound currently being considered for the treatment of depression, alters people's emotional states while listening to music. While listening to music, those who used psilocybin reported enhanced emotional processing. Researchers say combining music with psychedelic therapy may have positive benefits for those suffering from depression.

Featured Neuroscience Pain Psychology

·July 25, 2021·4 min read

The Future of Psychedelic Science

From treating depression and other mental health disorders, to helping relieve chronic pain, researchers discuss the advantages and implications of psychedelic treatments.

Featured Neuroscience Psychology

·July 5, 2021·2 min read

Psychedelic Spurs Growth of Neural Connections Lost In Depression

One dose of psilocybin, the psychoactive compound found in magic mushrooms, increases dendritic spine density within 24 hours. The neurobiological changes lasted for a month following psilocybin exposure. Additionally, mice subjected to stress showed behavioral improvements and increased neurotransmitter activity after psilocybin exposure.

This shows wild psilocybin cyanescens mushrooms

Featured Neuroscience Psychology

·April 16, 2021·8 min read

Psilocybin Performs At Least As Well as Leading Antidepressant in Small Study

Psilocybin, the psychoactive compound found in magic mushrooms, is as effective at treating depression as conventional SSRI antidepressants. Researchers report, that although not significantly significant, early findings reveal those treated with psilocybin experienced more rapid and greater reductions in depression symptoms than those treated with SSRIs.

This shows the outline of a head with a half moon inside

Featured Neuroscience Psychology

·April 13, 2021·4 min read

Psychedelic Experience May Not Be Required For Psilocybin’s Antidepressant-Like Benefits

A mouse study refutes the common belief that psilocybin's ability to produce an anti-depressant effect is attributed to the psychedelic experience it creates. Blocking the psychedelic effect did not affect psilocybin's anti-depressant effects.

Featured Neuroscience Psychology

·February 21, 2021·4 min read

From Trippy Drugs to Therapeutic Aids – How Psychedelics Got Their Groove Back

From microdosing to improve cognition, to treating a range of mental health disorders, researchers evaluate the rise in the use of psychedelics and their potential as medicines.

Featured Neurology Neuroscience

·November 23, 2020·2 min read

Psilocybin Shows Potential as Migraine Treatment

A new small scale study reveals psilocybin appears to have a beneficial effect for chronic migraine sufferers.

Featured Psychology

·November 4, 2020·5 min read

Psychedelic Treatment With Psilocybin Relieves Major Depression

Two doses of psilocybin in combination with therapy rapidly and significantly reduces symptoms in those with major depressive disorder. The effects appear to last for up to four weeks.

Featured Neuroscience Open Neuroscience Articles

·September 17, 2020·6 min read

How Psychedelics Bind to Key Serotonin Receptor

Researchers have uncovered the structure of psychedelic compounds when they actively bind to the 5-HT2A serotonin receptor on the surface of brain cells. The discovery could lead to the exploration of more precise compounds that offer the therapeutic effects of psychedelics for mental health disorders, but without the hallucinations.

Featured Neuroscience Open Neuroscience Articles Psychology

·April 17, 2020·3 min read

Psychedelic compound from magic mushrooms produced in yeast

Psilocybin can be produced de novo in yeast. The findings could help with the development of drugs that utilize the psychedelic compound to treat depression and other mental health disorders.

Featured Neuroscience Open Neuroscience Articles

·April 16, 2020·4 min read

Neuronal and neurotransmitter systems dynamic coupling explains the effects of psilocybin

Computational simulations reveal the integration of both neuronal and neurotransmitter systems at a whole-brain level is vital to fully understand the effects of psilocybin on brain activity.

1 … 3 4 5 6 7 8

psilocybin

Psychedelics Show Promise in Treating Mental Illness

Psilocybin Affects Perception of Music

The Future of Psychedelic Science

Psychedelic Spurs Growth of Neural Connections Lost In Depression

Psilocybin Performs At Least As Well as Leading Antidepressant in Small Study

Psychedelic Experience May Not Be Required For Psilocybin’s Antidepressant-Like Benefits

From Trippy Drugs to Therapeutic Aids – How Psychedelics Got Their Groove Back

Psilocybin Shows Potential as Migraine Treatment

Psychedelic Treatment With Psilocybin Relieves Major Depression

How Psychedelics Bind to Key Serotonin Receptor

Psychedelic compound from magic mushrooms produced in yeast

Neuronal and neurotransmitter systems dynamic coupling explains the effects of psilocybin

Cannabis Destroys Sleep Quality

Genetic Risk for Anorexia May Begin Outside the Brain

Higher BMI Linked to Longer Survival After a Dementia Diagnosis

Can We Predict Hearing Loss Long Before Symptoms Ever Start?

Subscribe